New York City, in addition to being a financial capital of the world, is also a major center for biotech. The New York/New Jersey region has long had the presence of top academic research institutions and a large number of top pharmaceutical companies, but it is also the top region for funding from the National Institutes of Health and third in terms of biotech jobs. We spoke to Nancy Kelley, president and CEO of Nancy J. Kelley and Associates and founding member of Builds Bio+, about the New York/New Jersey region for biotech, its strengths, and what’s ahead for the sector there.
